John drives Patient Innovations vision and strategy. He is deeply passionate about healthcare and developing innovative technologies and high value use cases that leverage datasets to improve access as well as clinical and operational efficiencies.
John is a healthcare and financial executive with 30 years of senior level management experience and has held numerous leadership positions with multi-geography P&L responsibility across a broad range of sectors and economic cycles. He has held the offices of Chief Executive Officer, Managing Partner, Corporate Treasurer, Chief Financial Officer, Chief Risk Officer, Investment Committee Chairman, Chief Growth Officer, Board Chairman and Board Director for privately held firms and public multi-national companies.
John has led merger and acquisition teams, has extensive private equity and investment banking experience and has led numerous joint ventures, strategic alliances and asset purchases. He has broad equity and debt capital markets experience and originated and securitized more than $16 billion in healthcare investment grade rated debt securities.
He has deep familiarity with highly regulated, complex and competitive environments. He has investment experience in products and services for patients and practitioners needing strategic growth capital to leverage consolidation efficiencies, improve clinical outcomes and reduce cost while improving patient engagement and physician satisfaction.
John was most recently the Chief Growth Officer of an outsourcing company engaged in providing operational and clinical support for physicians. He was responsible for revenue growth and augmenting organic growth initiatives. He drove significant revenue growth for the company including originating the largest clinical data migration engagement in the company’s history.
Previously, John was Managing Partner of Abacus Healthcare Partners and CEO of Abacus Finance. The firm was engaged by sponsors to assist with investment opportunities to source and execute control investments in medical device and ASC assets as well as GI practice consolidation.
Prior to Abacus John was Executive Vice President of Active International, a global corporate trading company and merchant bank headquartered in New York. The company provides innovative financial and operational solutions across multiple asset classes. John’s responsibilities included executing investments in distressed assets across several vertical markets including Healthcare and Life Sciences.
Before Active International, John was the Managing Partner, President & Chief Executive Officer of Capital Concepts Financial Group with a principal focus in MedTech and ASC consolidation. John was also the Chief Executive Officer of Phoenix Acquisition Corporation, a single strategy acquisition subsidiary. He led and secured a $650 Million commitment from a private equity firm, as part of a club deal with Kodak, for a $1.35 Billion bid to acquire an international global medical device and consumer electronics company. The investment thesis focused on increased adoption in a disposable diagnostic platform to minimize cross-contamination and infection control risk while making for more seamless clinical workflows.
Prior to Capital Concepts John was an executive at Olympus America, a multi-national company with a leading global market share across myriad modalities and services. During his sixteen year tenure he held numerous leadership positions including being a Corporate Officer, Board Chairman and Board Director as well as the Chief Financial Officer, Chief Risk Officer, Chief Investment Officer and Treasurer.
John was the Founder and Group Head of Olympus’s largest healthcare services business in the Americas. He grew the business from zero to several billion dollars and never had a down quarter during his tenure. He changed the entire go-to-market strategy and delivery paradigm which resulted in Olympus maintaining dominant share across markets while avoiding mature market margin decay. John created a capital markets group, managed banking and rating agency relationships and led multiple M&A engagements, JV’s and APA’s.
John holds a Bachelor of Science Degree from the City University of New York and an MBA in Finance from Long Island University, CW Post Graduate School of Business. He is a member of Delta Mu Delta. John attended the Kellogg School of Management at Northwestern University for the Advanced Executive Program, The Wharton School at the University of Pennsylvania for Healthcare Economics, Management and Policy and Leonard N. Stern School of Business at New York University for Enterprise Risk Management.
A believer in truly big ideas, Ken launched and co-founded Patient Innovations, LLC and created OnTimeCare, a cloud-based software solution initially conceived to eliminate waiting in doctor’s offices and optimize both practices and hospitals.
UnitedHealthcare (UHC) partnered with Patient Innovations to fund development of OnTimeCare. UHC featured OnTimeCare at its booth at the Consumer Electronics Show in Las Vegas as an emerging new technology that will offer competitive advantage – before the software was even written! Patient Innovations has nine patents pending on several of their innovative solutions.
Prior to founding Patient Innovations, Ken’s early career included 22 years in retail banking. Ken then co-founded Austin & Williams in 1992, a leading advertising and marketing consultancy headquartered on Long Island. Now known as AustinWilliams it’s Long Island’s most-awarded advertising agency, and serves three key verticals: banking, healthcare and higher education. Ken has always been fascinated by technology and brought AustinWilliams into the digital age in 1995. The agency has been growing its digital business ever since.
Ken is a product of Brooklyn College, where he earned a bachelor’s degree in economics. He is involved in several charities and trade organizations: YJP (the Young Jewish Professionals), the Long Island Association, Long Island Advancement of Small Business, (LIASB), American College of Healthcare Executives (ACHE), Direct Marketing Association – Long Island Chapter (DMALI), Health Leaders of NY (HLNY), The Beryl Institute and more.
In October 2014, Ken was inducted into the Direct Marketing Association of Long Island Hall of Fame. He’s the immediate past President of AJC’s Long Island Chapter. He also serves on the board of the Long Island Strategic Alliance (LISA) – a consortium of several small business trade groups.
In his five years as the president and CEO of MetroHealth, the public health system in Cleveland, Akram Boutros, MD, FACHE, has galvanized political leaders, entrepreneurs and the public around supporting community-wide healthcare many had taken for granted.
With his unwavering commitment to delivering high-quality healthcare to everyone in Cuyahoga County, Akram Boutros has achieved what many thought was impossible. Under his leadership, The MetroHealth System went to market on its own credit in 2017 and sold $946 million in bonds to rebuild its hospital, revitalize its main campus and resurrect its West Side neighborhood.
That is just one piece of the unprecedented transformation of Cuyahoga County’s public healthcare system Dr. Boutros has piloted since he arrived at MetroHealth in 2013. In the five years since, he has created an Integrated Delivery System that provides care at more than 20 community health centers, four emergency departments, four clinics in Discount Drug Mart stores, five MetroExpressCare locations and nine pharmacies. Those are in addition to MetroHealth’s main campus hospital, which is home to the area’s most experienced Level I Adult Trauma Center, a Level II Pediatric Trauma Center, one of two adult and pediatric burn centers in the state and Ohio’s only Ebola Treatment Center.
Now a more than $1 billion operation, MetroHealth and its caregivers treat patients at more than 1.4 million visits a year.
In the past five years, The MetroHealth System has also created more than 1,300 additional jobs, sent doctors into a dozen Cleveland schools and constructed an $82 million addition to its Critical Care Pavilion. Annual operating revenues under Akram’s leadership have grown from $783 million in 2012 to $1.13 billion in 2017. And last year, MetroHealth returned $231 million – 21.3 percent of its operating expenses – to Cuyahoga County in free care and community benefit programs. That is 2.3 times the national average.
An internist with a 25-year record of successful hospital leadership at academic medical centers, community hospitals and specialty hospitals, Dr. Boutros cultivates personal relationships throughout the hospital system and the community along with an atmosphere of personal excellence for everyone he works with.
As Co-Founder of Patient Innovations, Dr. Boutros contributed the vision for PatientPriority and SmartFactors and provided many valuable insights into our product development.
A graduate of St. John’s University, SUNY Downstate Medical Center and Harvard Business School’s Advanced Management Program, he has led organizations through strategic repositioning, operational redesign, clinical and physician integration and population-health and risk-contracting programs. He sees collaboration with other health systems, organizations and local residents as a key driver in fulfilling MetroHealth’s mission of leading the way to a healthier community.
Some of his recent awards include being named:
Jeff Alter is president of Arcturus One Consulting, providing advisory services to private equity and board of directors. He serves on numerous boards, for both for profit and not for profit organizations, including the Long Island Association, the board of governors of St. John’s University. CityMD, Professional Physical Therapy, NuMotion and Progenity.
He was formerly the Chief Executive Officer of UnitedHealthcare’s Commercial Group, serving nearly 30 million consumers. The Commercial Group manages health benefits for individuals, public sector employers, labor funds and businesses of all sizes, including more than half of the Fortune 100 companies. The organization also serves nearly three million active duty and retired U.S. military personnel and their families in the TRICARE West Region. Mr. Alter held that role from 2011 until June 2018.
From 2008 to 2011, Mr. Alter served as the Northeast Regional CEO for UnitedHealthcare. During his tenure, Mr. Alter strengthened the business by effectively serving employers’ and consumers’ health care needs, building relationships with brokers, government leaders and other constituents across the Northeast, and developing new and innovative programs and tools.
Mr. Alter previously served as chief operating officer of the Northeast Region.
Prior to joining UnitedHealthcare, Mr. Alter was vice president of strategic financial planning for Oxford Health Plans, where he led the company’s financial planning, merger and acquisition strategy and strategic initiatives.
Mr. Alter’s previous roles include seven years as vice president of finance and operations at Vytra Health Plans in addition to various finance and operations roles for 10 years for Grumman Aerospace and Harris Corporations.
Mr. Alter received a Bachelor of Science degree in Marketing and a Master of Business Administration degree in finance from St. John’s University. He is actively involved in supporting his alma maters, including St. Francis Preparatory School.
Cathleen D. Bennett, Esq., took the helm November 9, 2017, as president and CEO of the New Jersey Hospital Association, a nonprofit trade association representing New Jersey’s hospitals, health systems, behavioral healthcare systems, rehabilitation hospitals, psychiatric hospitals, assisted living, nursing homes and other healthcare providers that provides leadership on quality and patient safety, education and advocacy in both Washington, D.C. and in Trenton.
As CEO, Bennett oversees NJHA, the Health Research and Educational Trust of New Jersey, a not-for-profit affiliate that promotes continuing education, patient safety, quality improvement and research; and the for-profit Healthcare Business Solutions, which provides group purchasing and other business solutions for healthcare providers. She also co-founded Q3HIP, LLC in 2018 with a focus on improving quality of care, patient safety and education in addition to leveraging the collective capabilities of the Hospital Associations of New Jersey, Pennsylvania and Ohio.
Prior to being selected as CEO of NJHA, Bennett served as New Jersey’s 20th Health Commissioner. As Commissioner, she established her top priority by creating an Office of Population Health to promote stronger collaboration among hospitals, local health departments and healthcare providers. She convened an unprecedented Population Health Action Team, which brought eight state departments together to strategize on how to improve health in all policies. Bennett also transitioned the Division of Mental Health and Addiction Services and four state psychiatric hospitals from the Department of Human Services to the Department of Health’s new Integrated Health Services branch, in recognition that good health encompasses the whole person.
Bennett began her career in the private sector, with 15 years of experience as an executive, providing consulting, strategy and management services to federal and state health and human services agencies. Bennett holds a Master of Public Administration from the University of Pennsylvania, a Juris Doctorate from The Dickinson School of Law and a Bachelor of Arts from Villanova University.
Robin is the director of software development businesses in the UK and Australia. He has 30 years of commercial software experience and is the architect of several market-leading applications and software systems used worldwide
Prior to forming his own enterprises, Robin was the IT Manager for one of the UK’s energy businesses with annual revenue exceeding $1 billion and a software development team of 200 professionals. He has also worked as a consultant IT Manager and visiting lecturer in software development and Internet security.
Appointed Fellow of the Institution of Analysts and Programmers in recognition of his experience and contribution to the software industry, Robin is also a Member of the Institute of Directors and holds an MA from Oxford University in Mathematics and Computation.
Joseph R. Ficalora is the President and Chief Executive Officer and a director of New York Community Bancorp – the 25th largest bank holding company in the nation – and of its subsidiary, New York Community Bank. Under Mr. Ficalora’s leadership, the company evolved from a mutual savings bank with seven branches in Queens and Nassau Counties to a publicly traded multi-bank holding company with 251 branch offices serving consumers and businesses throughout Metro New York, New Jersey, Florida, Ohio, and Arizona.
A graduate of Pace University with a degree in business and finance, Mr. Ficalora provides leadership to several professional banking organizations. He currently serves as a Member Director of the Federal Home Loan Bank of New York, a member of the American Bankers Council of the American Bankers Association, a member of the American Bankers Association’s Government Relations Council Administrative Committee, and is a director of the New York Bankers Association, also serving as Chairman of its Metropolitan Area Division. Mr. Ficalora also serves on the board of trustees of Pace University, as well as on their investment/pension committee, the boards of directors of the New York Community Bank Foundation, the Richmond County Savings Foundation, Pentegra Retirement Trust, and Peter B. Cannell & Co., Inc., an investment advisory firm. In addition, he is a member of the Board of Pentegra Services, Inc.
Mr. Ficalora also is an active participant in community affairs. He has been a member of the board of directors of the Queens Chamber of Commerce since 1990 and previously served on its executive committee. In addition, Mr. Ficalora serves on the boards of directors of the Foreign Policy Association, Partnership for New York City, and Flushing Cemetery, the board of directors, the executive committee, and the development committee of New York-Presbyterian/Queens, the board of trustees and the finance and audit committee of the New York Hall of Science, and the advisory council of the Queens Museum of Art.
Mr. Ficalora is the former vice chairman of the Federal Home Loan Bank of New York, a former member of the board of directors of the American Bankers Association, the Thrift Institutions Advisory Council of the Federal Reserve Board in Washington, and the Federal Reserve Bank of New York Thrift Institutions Advisory Panel. He is also the former chairman of the New York State Savings Forum for Operations Audit Control, the former Chairman of CBANYS, as well as the former chairman of CBANYS’ Auditors and Comptrollers Forum, the former chairman of the SBLI Fund, the former director of Computhrift Corporation, a former trustee of the Museum of the Moving Image, and past president and director of the MSB Fund. In addition, he previously served as president of the Queens Library Foundation and as chairman of the board of the administrative committee of the Queens Borough Public Library.
Dr. Satava is Professor Emeritus of Surgery, University of Washington Medical Center in Seattle, Washington.
Prior academic positions include Professor of Surgery at Yale University and a military appointment as Professor of Surgery (USUHS) in the Army Medical Corps assigned to General Surgery at Walter Reed Army Medical Center.
Government positions included Program Manager of Advanced Biomedical Technology at the Defense Advanced Research Projects Agency (DARPA) for 12 years and Senior Science Advisor at the US Army Medical Research and Materiel Command in Ft. Detrick, Maryland, and Director of the NASA Commercial Space Center for Medical Informatics and Technology Applications at Yale University. Upon completion of military career and government service he had continued clinical medicine at Yale University and the University of Washington.
His undergraduate training was at Johns Hopkins University, Medical School at Hahnemann University of Philadelphia, Internship at the Cleveland Clinic, Surgical Residency at the Mayo Clinic, and a Fellowship with a Master of Surgical Research at Mayo Clinic.
He has served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety and was also awarded the prestigious Department of Defense Legion of Merit and Department of Defense Exceptional Service medals as well as awarded the Smithsonian Laureate in Healthcare.
Dr. Satava has been a member of numerous committees of the American College of Surgeons (ACS), currently serving on the ACS-Accredited Education Institutes (ACS-AEI).
He is a Past President of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), the Society of Laparoendoscopic Surgeons (SLS), and the Society of Medical Innovation and Therapy (SMIT). He was a member of the National Board of Medical Examiners (NBME) and is currently on the Board of many surgical societies and on the editorial board of numerous surgical and scientific journals, and active in a number of surgical and engineering societies.
Dr. Satava was the surgeon on the project that developed the first surgical robot, which later became the DaVinci Surgical Robot. In addition, as a government official, he funded all of the surgical robot development for the first 10 years, until commercialization became possible.
For 5 years he was a member of the Advisory Board of the National Space Biomedical Research Institute (NSBRI) advising NASA in surgical robotics, advanced biometric sensing and other life science research for astronauts.
Now Dr. Satava has added being continuously active in surgical education and surgical research, with more than 200 publications and book chapters in diverse areas of advanced surgical technology, including Surgery in the Space Environment, Video and 3-D imaging, Plasma Medicine, Directed Energy Surgery, Telepresence Surgery, Robotic Surgery, Virtual Reality Surgical Simulation, Objective Assessment of Surgical Competence and Training and the Moral and Ethical Impact of Advanced Technologies.
During his 23 years of military surgery he has been an active flight surgeon, an Army astronaut candidate, combat tours of duty as MASH surgeon for the Grenada Invasion, and a hospital commander during Desert Storm, all the while continuing clinical surgical practice. Current research is focused on advanced technologies to formulate the architecture for the next generation of clinical Medicine and Surgery, education and training.
For more than 25 years, Rodney has been intimately involved in the healthcare industry and has positioned organizations to adapt to the continuously and rapidly changing healthcare environment. He has worked with boards, physicians, employees and the community to strengthen core services to customers, optimize performance and identify best practices and strategic alliances for new business development.
Rodney’s ability to think strategically and hold a long-term focus while providing leadership that draws physicians, employees and others toward a common goal is a skill he brings to Patient Innovations.
As an enthusiastic leader, he is able to motivate his team by identifying each team member’s strengths; incorporating these strengths into a specific and unique role for each team member.
Dr. Stock is a physician leader with experience providing operational and service line leadership and strategy to medical staff and other key health system stakeholders in support of high-value care delivery. He has been a trusted advisor to improve organizational performance and enhance competitive advantage, with particular expertise in and diagnostic medical technologies that drive growth and innovation.
Dr. Stock served as Director within PwC’s Strategic Transformation and Clinical Operations Group of Health Industries Advisory between May 2015 and October 2018. In this role, He leveraged his real world understanding of clinical practice and care management principles to help provider clients preserve/grow margins and achieve value-based partnerships and clinically integrated networks.
Dr. Stock drove xLOS pursuits/engagements across the healthcare ecosystem, including Pharma Life Science, Payor and M&A, with distinctive client impact including: multiyear, multimillion-dollar enterprise data warehouse (EDW) design and build for MD Anderson, the nation’s leading NCI-designated comprehensive cancer center; utilization management program design for the Veteran Health Administration’s nationally deployed community care network; assessment of a leading regional payor’s (BCBS) disease management and population health programs, as well as support for a new, integrated care management platform solution; strategic planning for a regional health system’s cancer center, including market perspectives on emerging trends in oncology, academic-community hybrid models and industry partnerships for precision medicine and related biomarker data capture and insight generation.
Dr. Stock was an advisory team member and a key contributor to PwC’s Health Research Institute, receiving the Health Industries Advisory distinguished thought leadership award for 2016. He has been cited in Healthcare Executive and Healthcare Dive, and was recently published in Becker’s Hospital Review (“Health Systems Strategy: What’s needed now.” November, 2018).
A board-certified radiologist with subspecialty expertise in musculoskeletal conditions and image-guided interventions, Dr. Stock previously served as assistant professor and chief of musculoskeletal radiology at UCONN Health Center from September 2010 to May 2015.
In addition to his clinical responsibilities, Dr. Stock was an instructor to radiology and orthopedic residents, as well as medical students, staff and sports medicine fellows. He oversaw the department’s musculoskeletal curriculum and was deeply involved in academic pursuits, including teaching/mentorship, peer-reviewed publications and journal reviews. He has been an invited lecturer for the American Orthopaedic Society for Sports Medicine (AOSSM).
Dr. Stock received his post-graduate medical training at Lenox Hill Hospital (medicine internship; diagnostic radiology residency), Memorial Sloan Kettering Cancer Center (nuclear medicine fellowship) and Hospital for Special Surgery (musculoskeletal radiology fellowship).
Minds Matter NYC, preparing underprivileged high school students for college success
Dr. James Tsai is the president of New York Eye and Ear Infirmary of Mount Sinai, the nation’s first and longest operating specialty hospital. He also serves as system chair and Delafield-Rodgers Professor of Ophthalmology for the Mount Sinai Health System.
Tsai earned his Doctor of Medicine degree from Stanford University and Master of Business Administration from Vanderbilt University. He completed his ophthalmology residency at USC-Doheny Eye Institute and glaucoma fellowships at Bascom Palmer Eye Institute and Moorfields Eye Hospital.
Dr. Wu is a practicing physician at Maimonides Hospital in Brooklyn and serves as Chief Medical Officer for The New Jewish Home.
As a primary care physician, he has seen the impact of wellness/mental health on chronic conditions and overall health. At the New Jewish Home, he is blending technology, quality and innovations in health to improve care for the residents. Dr. Wu leverages data and evidence-based care to drive collaborative decision-making to improve healthcare outcomes. He strategizes with companies and health systems to enhance wellness, care quality, and access initiatives. Prior to joining the New Jewish Home, he was responsible for Spring Health’s clinical operations, population health initiatives, regulatory/compliance, HIPAA/GDPR, patient satisfaction, account management and practitioner recruitment/relations.
Previously, Dr. Wu designed and implemented solutions (both IT and non-IT) for healthcare organizations that optimize clinical operations and population health. Working across the spectrum of fee-for-service to full-risk care models, he has led teams in crafting clinical solutions to optimize care, quality and efficiency. His expertise also includes early-stage company growth, business development and strategy.